Scientists Develop a New Molecule That Blocks COVID-19 Infection
A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus…
A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus…
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida (UF) Health researchers have…
Vaccines and previous infection could offer some “stronger than basic” protection to Omicron, early study suggests. Tube samples of Omicron, however, do further propose its…
A team of researchers at the MUSC Shawn Jenkins Children’s Hospital contributed to a nationwide study on the effectiveness of Pfizer-BioNTech’s COVID-19 vaccine against hospitalization…
Skoltech scientists and their colleagues have looked at the genetic makeup of the dominant strain of the COVID-19 coronavirus, the delta variant, in Russia. According…
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that…
If the omicron variant of the coronavirus is different enough from the original variant, it’s possible that existing vaccines won’t be as effective as they…
Protein region on COVID’s viral spike senses temperature, drives seasonal mutation patterns. Not to pile on, but winter is coming and the COVID-19 pandemic is…
The emergence of COVID-19 variants such as delta and omicron have sent scientists scrambling to determine whether existing vaccinations and boosters are still effective against…
A quiet months-long legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently burst into public view. The…
Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems. Researchers in…
A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds. The…
A discovery by researchers at the Texas A&M College of Medicine could lead to new therapies to prevent the virus from proliferating in the human…
DNA damage signaling induced by aging telomeres increases the expression of ACE2, the human SARS-CoV-2 cell receptor. SARS-CoV-2 causes the pandemic coronavirus disease COVID-19, that…
New research reveals the economic costs of behavioral responses to the pandemic in the U.S. Throughout its unsteady course, the COVID-19 pandemic has altered the…
Antibodies against the SARS-CoV-2 spike protein produced by the immune system can help identify and fend off future infections, but not all antibodies are the…
Most adolescents and young adults with suspected myocarditis following a COVID-19 vaccination experience mild symptoms and rapid clinical recovery, though many had evidence of continued…
Center for Translational Antiviral Research Reports Novel Drug Class with Activity Against SARS-CoV-2 The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses…